Publications by authors named "Jean Marc Lablanche"

Claim this Profile
P
Poor agreement between light transmission aggregometry, Verify Now P2Y₁₂ and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: a potential explanation of negative results of recent randomized trials.
Gilles Lemesle, Jean-Baptiste Landel, Anne Bauters, Cédric Delhaye, Laurent Bonello, Jean-Marc Lablanche

Platelets· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of initial clinical presentation on clopidogrel low response.
Jean-Baptiste Landel, Anne Bauters, Cédric Delhaye, Laurent Bonello, Arnaud Sudre, Jean-Marc Lablanche

Arch Cardiovasc Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term prognostic value of preprocedural adiponectin levels in patients undergoing percutaneous coronary intervention.
Cédric Delhaye, Natalia Kpogbemabou, Thomas Modine, Gilles Lemesle, Bart Staels, Jean-Marc Lablanche

Int J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
Michaël Angioi, Paul Barragan, Simon Cattan, Frédéric Collet, Patrick Dupouy, Jean-Marc Lablanche

Arch Cardiovasc Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
Didier Carrié, Hélène Eltchaninoff, Thierry Lefèvre, Marc Silvestri, Philippe Brunel, Jean Marc Lablanche

EuroIntervention· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.
Gilles Lemesle, Francesco Paparoni, Cedric Delhaye, Laurent Bonello, Jean-Marc Lablanche

Hosp Pract (1995)· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual evolution of an aneurysm of the proximal left anterior descending coronary artery 15 years after a Simpson atherectomy.
Gilles Lemesle, Christophe Lions, Jean-Marc Lablanche

Arch Cardiovasc Dis· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.
Gilles Lemesle, Arnaud Sudre, Rachid Bouallal, Cédric Delhaye, Guillaume Rosey, Jean-Marc Lablanche

Cardiovasc Revasc Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
Cédric Delhaye, Arnaud Sudre, Gilles Lemesle, Laure Vanesson, Mohamad Koussa, Jean-Marc Lablanche

Arch Cardiovasc Dis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Uwe Zeymer, Alain Margenet, Michael Haude, Christoph Bode, Jean-Marc Lablanche

J Am Coll Cardiol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.
Gilles Lemesle, Gabriel Maluenda, Laurent Bonello, Cedric Delhaye, Arnaud Sudre, Jean Marc Lablanche

Hosp Pract (1995)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.
Jean-Marc Lablanche, Attilio Leone, Bela Merkely, João Morais, Joaquim Alonso

Arch Cardiovasc Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombus aspiration for the treatment of definite stent thrombosis.
Gilles Lemesle, Rachid Bouallal, Arnaud Sudre, Cédric Delhaye, Guillaume Rosey, Jean-Marc Lablanche

Arch Cardiovasc Dis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of an international, common, prospective, cardiology database. Report of the joint G8 Cardio-Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)--Societé Française de Cardiologie (SFC) database committee.
Christian Pristipino, Nicholas Danchin, Jean Marc Lablanche, Michel Komajda, Marco Tubaro

Acute Card Care· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Cédric Delhaye, Arnaud Sudre, Gilles Lemesle, Sylvestre Maréchaux, Damien Broucqsault, Jean-Marc Lablanche

Cardiovasc Revasc Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
Gilles Lemesle, Cédric Delhaye, Arnaud Sudre, Damien Broucqsault, Guillaume Rosey, Jean-Marc Lablanche

Am Heart J· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
Jean-Charles Fruchart, Frank M Sacks, Michel P Hermans, Gerd Assmann, W Virgil Brown, Jean-Marc Lablanche

Diab Vasc Dis Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
Jean-Charles Fruchart, Frank Sacks, Michel P Hermans, Gerd Assmann, W Virgil Brown, Jean-Marc Lablanche

Am J Cardiol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.
Gilles Lemesle, Arnaud Sudre, Thomas Modine, Cédric Delhaye, Guillaume Rosey, Jean-Marc Lablanche

Catheter Cardiovasc Interv· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
Jean-Marc Lablanche, Nicolas Danchin, Michel Farnier, Alain Tedgui, Eric Vicaut

Arch Cardiovasc Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Jacques Machecourt, Nicolas Danchin, Jean Marc Lablanche, Jean Marie Fauvel, Jean Louis Bonnet

J Am Coll Cardiol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of myocardial infarction in hospitals with percutaneous coronary intervention facilities.
Jose Labarere, Loic Belle, Magali Fourny, Nathalie Genès, Jean-Marc Lablanche

Arch Intern Med· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute coronary syndromes associated with thrombus in the sinus of valsalva and normal coronary arteriography: the pivotal role of transesophageal echocardiography in the intensive care unit.
Pmerre V Ennezat, Arnaud Sudre, Sebastien Pouwels, Jean M Aubert, Hélène Cordova, Jean-Marc Lablanche

Mayo Clin Proc· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective aortic screening in men with coronary aneurysms.
Nicolas Lamblin, Corinne Gautier, Thierry Le Tourneau, Jean-Marc Lablanche, Ghislaine Deklunder

J Am Coll Cardiol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous coronary interventions in Europe 1992-2003.
Stéphane Cook, Mario Togni, Nazan Walpoth, Willibald Maier, Volker Muehlberger, Jean-Marc Lablanche

EuroIntervention· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis